643 related articles for article (PubMed ID: 12714955)
21. 99mTc-MIBI imaging of cutaneous AIDS-associated Kaposi's sarcoma.
Peer FI; Pui MH; Mosam A; Rae WI
Int J Dermatol; 2007 Feb; 46(2):166-71. PubMed ID: 17269969
[TBL] [Abstract][Full Text] [Related]
22. 99mTc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy.
Furuta M; Nozaki M; Kawashima M; Iimuro M; Kitazumi Y; Okayama A; Natsui S; Hamashima Y; Nagao K
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):982-7. PubMed ID: 12734691
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
24. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
[TBL] [Abstract][Full Text] [Related]
25. Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors.
Taki J; Sumiya H; Higuchi T; Tsuchiya H; Takazawa K; Tomita K; Tonami N
J Nucl Med; 2002 Nov; 43(11):1452-6. PubMed ID: 12411547
[TBL] [Abstract][Full Text] [Related]
26. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
29. Application of the alteration uptake ratio of
Huang Z; Lou C
Hell J Nucl Med; 2018; 21(1):55-59. PubMed ID: 29705817
[TBL] [Abstract][Full Text] [Related]
30. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
31. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
[TBL] [Abstract][Full Text] [Related]
35. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
36. Tc-99m MIBI to evaluate children with Ewing's sarcoma.
Bar-Sever Z; Cohen IJ; Connolly LP; Horev G; Perri T; Treves T; Hardoff R
Clin Nucl Med; 2000 Jun; 25(6):410-3. PubMed ID: 10836685
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
[TBL] [Abstract][Full Text] [Related]
38. Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CT.
Du C; Ying H; Zhou J; Jiang J; Liu C; Chen J; Wang X; Hu C
Med Oncol; 2014 Feb; 31(2):833. PubMed ID: 24402323
[TBL] [Abstract][Full Text] [Related]
39. "Double imaging" for the diagnostic work-up of alveolar soft part sarcoma with Tc-99m MIBI.
Demir H; Berk F; Memisoglu K; Arslan A; Muezzinoglu B; Erdincler RO; Isgoren S; Sarlak A; Aktolun C
Ann Nucl Med; 2002 Apr; 16(2):151-5. PubMed ID: 12043911
[TBL] [Abstract][Full Text] [Related]
40. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors.
Bleichner-Perez S; Le Jeune F; Dubois F; Steinling M
Nucl Med Commun; 2007 Dec; 28(12):888-94. PubMed ID: 18090213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
